Yishu F. Wang
160 Pujian Road
Shanghai, 200127, China
Shanghai, 200127, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 70 publications
Lactylation in cancer: Metabolic-epigenetic nexus and therapeutic frontiers.
Journal: Critical reviews in oncology/hematology
Published: October 20, 2025
Rapid establishment of KRAS-driven bladder cancer initiation and immune escape models using genetically engineered mice and organoid approaches.
Journal: Frontiers in immunology
Published: October 20, 2025
HNRNPU K181 Lactylation Drives Cervical Cancer Growth by Upregulating PHGDH and Reprogramming Serine Metabolism.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 12, 2025
Loss of ACSL1 fuels ferroptosis resistance in clear cell renal carcinoma.
Journal: Cancer biology & therapy
Published: October 07, 2025
Sex-specific mechanisms in the pathogenesis and progression of chronic kidney disease.
Journal: Autoimmunity reviews
Published: June 10, 2025
EPI-SauriCas9-based mouse ovarian cancer models recapitulating pten deletion in patients.
Journal: Communications biology
Published: April 09, 2025
Omega-3 polyunsaturated fatty acids alleviate renal fibrosis in chronic kidney disease by reducing macrophage activation and infiltration through the JAG1-NOTCH1/2 pathway.
Journal: International immunopharmacology
Published: February 01, 2025
Activation of TLR4-NF-κB signaling in renal tubular epithelial cells facilitates renal allograft fibrosis by inhibiting peroxisome biogenesis.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: November 16, 2024
Role of peroxisomes in the pathogenesis and therapy of renal fibrosis.
Journal: Metabolism: clinical and experimental
Published: October 06, 2024
APP-CD74 axis mediates endothelial cell-macrophage communication to promote kidney injury and fibrosis.
Journal: Frontiers in pharmacology
Published: May 23, 2024
Causal effects of plasma metabolites on chronic kidney diseases and renal function: a bidirectional Mendelian randomization study.
Journal: Frontiers in endocrinology
Published: May 14, 2024
Gut microbiome: a novel preventive and therapeutic target for prostatic disease.
Journal: Frontiers in cellular and infection microbiology
Published: May 11, 2024
Last Updated: 09/26/2026